{"article_title": "CVS Reports A Strong Q4'13 Backed By Growth In Retail Pharmacy &amp; Services", "article_keywords": ["retail", "cvs", "reports", "pharmacy", "backed", "growth", "strong", "services", "amp", "q413"], "article_url": "http://www.forbes.com/sites/greatspeculations/2014/02/13/cvs-reports-a-strong-q413-backed-by-growth-in-retail-pharmacy-services/", "article_text": "", "article_metadata": {"description": "On a 12-month basis, CVS estimates that it will loose approximately $2 billion in annual revenue from tobacco sales and an additional $0.5 billion from the rest of the shoppers\u2019 basket. Given the expected timing for implementing this change, this will cost $0.06 to $0.09 per share in 2014.", "author": "Great Speculations", "og": {"site_name": "Forbes", "description": "On a 12-month basis, CVS estimates that it will loose approximately $2 billion in annual revenue from tobacco sales and an additional $0.5 billion from the rest of the shoppers\u2019 basket. Given the expected timing for implementing this change, this will cost $0.06 to $0.09 per share in 2014.", "title": "CVS Reports A Strong Q4'13 Backed By Growth In Retail Pharmacy &amp; Services", "url": "http://www.forbes.com/sites/greatspeculations/2014/02/13/cvs-reports-a-strong-q413-backed-by-growth-in-retail-pharmacy-services/", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "updated_time": "2014-02-13T08:46:28-05:00", "type": "article"}, "twitter": {"site": "@forbes", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "description": "On a 12-month basis, CVS estimates that it will loose approximately $2 billion in annual revenue from tobacco sales and an additional $0.5 billion from the rest of the shoppers\u2019 basket. Given the expected timing for implementing this change, this will cost $0.06 to $0.09 per share in 2014.", "card": "summary_large_image", "title": "CVS Reports A Strong Q4'13 Backed By Growth In Retail Pharmacy &amp; Services"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Investing,Markets,Stocks,Cardinal Health,CVS Caremark,Express Scripts,walgreen", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/investing", "section": "Investing", "modified": "2014-02-13", "published": "2014-02-13", "id": "blogAndPostId/blog/post/25-121294"}, "news_keywords": "Investing,Markets,Stocks,Cardinal Health,CVS Caremark,Express Scripts,walgreen", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "prerender-status-code": "{{meta.code}}"}, "_id": "\"57477af36914bd0286fd245b\"", "article_summary": ""}